| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |